research Bioiberica Farma Hyalgan ® grants awarded two projects on regeneration of cartilage.
-Work on tissue engineering applied to cartilage regeneration and another on the effects of the use of amniotic membrane in cartilage injuries articulate received two grants in chondroprotection which gives the Chair Bioiberica of the University of Coruña.
-Awardsendowed each of them with 12,000 euros, they have been delivered within the framework of the forty-sixth national Congress of the Spanish society of orthopedic surgery and orthopaedic (SECOT).
Barcelona, September 2009.- The Bioiberica Chair of the University of Coruña has delivered on its third session, research grants to the two best national projects in chondroprotection, each endowed with 12,000 euros. The Act has been developed within the framework of the forty-sixth national Congress of the Spanish society of orthopedic surgery and orthopaedic (SECOT), which this year was held in Barcelona.
The draft prepared by a research team of the tissue establishment Foundation clinic San Francisco (León) under the title tissue engineering cartilage regeneration joint: condrocitos joints with stem cells from adipose tissue embedded in fibrin matrix antóloga and hyaluronic acid ” has been awarded one of the research fellowshipsdoes. The other winner was the project headed by the Dr. Diego GarcÃa RodrÃguez of the Hospital Universitario Puerta de Hierro Majadahonda (Madrid) with the title effects of the use of amniotic membrane in fresco in the regeneration condral sheep ”.
Both projects, in line with the new pathways of cell research applied to the chondroprotection, are aimed at the regeneration of cartilage and the conclusions of the work will be presented at the National Congress of the SECOT in 2010. On the other hand, the delivery of the financial envelope will be implemented in different sections, according to the achievement of the objectives specified in the work.
On 18 September the evaluating Committee of the 2009 Hyalgan scholarships chose two projects from all the papers, which had been made primarily in the fields of pharmacological research clinical or experimental with SYSADOA (CondrotÃn sulfate, glucosamine, hyaluronic acid) on the prevention and treatment of the pathology articulate.
The aim of these research grants is therefore promote, recognize and encourage research in Spain in the field of the chondroprotection. Thus, at the end of the studies be published a summary of the reports on the website www.condroproteccion.es and, wherever possible, be they disseminated in Spanish publications and/or foreign.
Pharma Division of Bioiberica
Bioiberica Farma works specializing in the research and development of effective drugs that offer better therapeutic alternatives in CONDROPROTECCION to prevent, delay, stabilize and repair or reverse injury of cartilage, synovial membrane and/or the bone subcondral. Currently available in Spain of 3 drugs condroprotectores indicated for the treatment of osteoarthritis: chondroitin sulfate, hyaluronic acid and glucosamine sulfate.
